Cargando…
Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135713/ https://www.ncbi.nlm.nih.gov/pubmed/37189444 http://dx.doi.org/10.3390/biom13040697 |
_version_ | 1785032044999344128 |
---|---|
author | Pełech, Aleksandra Ruszała, Monika Niebrzydowska-Tatus, Magdalena Bień, Katarzyna Kimber-Trojnar, Żaneta Czuba, Monika Świstowska, Małgorzata Leszczyńska-Gorzelak, Bożena |
author_facet | Pełech, Aleksandra Ruszała, Monika Niebrzydowska-Tatus, Magdalena Bień, Katarzyna Kimber-Trojnar, Żaneta Czuba, Monika Świstowska, Małgorzata Leszczyńska-Gorzelak, Bożena |
author_sort | Pełech, Aleksandra |
collection | PubMed |
description | Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations in healthy pregnant women and those with GDM. Galectin-9 levels were assessed in serum samples taken both just before and after delivery, as well as in urine samples collected in the postpartum period. Maternal body composition and hydration status were evaluated using the bioelectrical impedance analysis (BIA) method. There were no statistically significant differences in the concentration of galectin-9 in women with GDM compared to healthy pregnant women in their serum samples taken just before delivery, nor in their serum and urine samples collected in the early postpartum period. However, serum galectin-9 concentrations taken before delivery were positively correlated with BMI and parameters related to the amount of adipose tissue assessed in the early postpartum period. Additionally, there was a correlation between serum galectin-9 concentrations taken before and after delivery. Galectin-9 is unlikely to become a diagnostic marker for GDM. However, this subject requires further clinical research in larger groups. |
format | Online Article Text |
id | pubmed-10135713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101357132023-04-28 Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study Pełech, Aleksandra Ruszała, Monika Niebrzydowska-Tatus, Magdalena Bień, Katarzyna Kimber-Trojnar, Żaneta Czuba, Monika Świstowska, Małgorzata Leszczyńska-Gorzelak, Bożena Biomolecules Article Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations in healthy pregnant women and those with GDM. Galectin-9 levels were assessed in serum samples taken both just before and after delivery, as well as in urine samples collected in the postpartum period. Maternal body composition and hydration status were evaluated using the bioelectrical impedance analysis (BIA) method. There were no statistically significant differences in the concentration of galectin-9 in women with GDM compared to healthy pregnant women in their serum samples taken just before delivery, nor in their serum and urine samples collected in the early postpartum period. However, serum galectin-9 concentrations taken before delivery were positively correlated with BMI and parameters related to the amount of adipose tissue assessed in the early postpartum period. Additionally, there was a correlation between serum galectin-9 concentrations taken before and after delivery. Galectin-9 is unlikely to become a diagnostic marker for GDM. However, this subject requires further clinical research in larger groups. MDPI 2023-04-20 /pmc/articles/PMC10135713/ /pubmed/37189444 http://dx.doi.org/10.3390/biom13040697 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pełech, Aleksandra Ruszała, Monika Niebrzydowska-Tatus, Magdalena Bień, Katarzyna Kimber-Trojnar, Żaneta Czuba, Monika Świstowska, Małgorzata Leszczyńska-Gorzelak, Bożena Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study |
title | Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study |
title_full | Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study |
title_fullStr | Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study |
title_full_unstemmed | Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study |
title_short | Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study |
title_sort | do serum galectin-9 levels in women with gestational diabetes and healthy ones differ before or after delivery? a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135713/ https://www.ncbi.nlm.nih.gov/pubmed/37189444 http://dx.doi.org/10.3390/biom13040697 |
work_keys_str_mv | AT pełechaleksandra doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT ruszałamonika doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT niebrzydowskatatusmagdalena doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT bienkatarzyna doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT kimbertrojnarzaneta doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT czubamonika doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT swistowskamałgorzata doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy AT leszczynskagorzelakbozena doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy |